Related Experiment Video
Updated: Nov 1, 2025
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.6K
Acute-on-chronic liver failure: Where do we stand?
François Durand1,2,3, Olivier Roux1, Emmanuel Weiss2,4
1Hepatology & Liver Intensive Care Hospital Beaujon, Clichy, France.
Summary
Acute-on-chronic liver failure (ACLF) involves rapid organ failure in cirrhosis patients, with high mortality. Early identification and ICU care are crucial for managing this severe liver condition.
Area of Science:
- Hepatology
- Critical Care Medicine
- Gastroenterology
Background:
- Acute-on-chronic liver failure (ACLF) is a severe complication of cirrhosis with high short-term mortality.
- ACLF is graded by organ failure severity, with Grade 3 having >70% 28-day mortality.
- Definitions and precipitating factors for ACLF vary, with nearly 60% of cases lacking an identifiable cause.
Purpose of the Study:
- To review the definition, grading, and prognosis of ACLF.
- To discuss precipitating factors, including systemic inflammation and gut translocation.
- To highlight management strategies and the role of intensive care and transplantation.
Main Methods:
- Review of existing literature on ACLF definitions and clinical characteristics.
- Analysis of prognostic scores like the CLIF-C ACLF score.
- Discussion of management options including ICU admission and liver transplantation.
Main Results:
- ACLF has distinct grades correlating with mortality.
- The CLIF-C ACLF score aids prognosis.
- Bacterial infections and variceal bleeding are common, but often unidentified precipitating factors exist.
- Systemic inflammation and gut permeability may contribute to ACLF development.
Conclusions:
- ACLF requires careful management, including ICU admission for organ failure.
- Rescue liver transplantation offers survival benefits in selected severe cases.
- Further research is needed on preventative therapies like statins, rifaximin, and albumin.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
46
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
46
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
43
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
43
01:22Acute Kidney Injury I: Introduction
212
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
212
01:29Acute Kidney Injury III: Clinical Manifestations
359
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
359
01:29Acute Kidney Injury II: Pathophysiology
432
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
432
01:27Acute Pancreatitis I: Introduction
751
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
751